The effect of Arctium Lappa root powder in women with polycystic ovary syndrome - Trial IRCT20230222057492N1
Access comprehensive clinical trial information for IRCT20230222057492N1 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Arak University of Medical Sciences and is currently Recruiting. The study focuses on Polycystic ovarian syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20230222057492N1
Phase 2/3
Recruiting
biological
Trial Details
Iranian Registry Of Clinical Trial • IRCT20230222057492N1
The effect of Arctium Lappa root powder in women with polycystic ovary syndrome
Effects of Arctium Lappa root powder on some markers of oxidative stress and inflammation in women with polycystic ovary syndrome: a randomized double blind clinical trial study
Study Focus
Sponsor & Location
Arak University of Medical Sciences
Iran
Timeline & Enrollment
Phase 2/3
Apr 04, 2023
N/A
ICD-10 Classifications
Polycystic ovarian syndrome
Ovarian dysfunction, unspecified
Ovarian dysfunction
Other ovarian dysfunction
Other and unspecified ovarian cysts
Data Source
Iranian Registry Of Clinical Trial
IRCT20230222057492N1
Non-Device Trial